Impact of Endobronchial Valve Treatment on Lung Function Decline.

Authors:
Hartman JE; Klooster K; Koster TD; Carpaij OA; van Dijk M and 1 more

Journal:
Respiration

Publication Year: 2023

DOI:
10.1159/000534673

PMCID:
PMC10733934

PMID:
37939683

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Respiration

Abbreviation: Respiration

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Pulmonary Medicine

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
Photon Counting Computed Tomography with the Radiation Dose of a Chest X-Ray: Feasibility and Diagn…
Dettmer S; Werncke T; Mitkovska VN and 6 more (2024) - Transparency Score: 3/6
Bronchoscopic Evaluation of a Steerable Needle for Simulated Tumor Targets in the Lung Periphery: A…
Chen AC; Machuzak M; Cheng G and 1 more (2023) - Transparency Score: 3/6
Centrilobular Emphysema Is Associated with Pectoralis Muscle Reduction in Current Smokers without A…
Maetani T; Tanabe N; Shiraishi Y and 11 more (2023) - Transparency Score: 3/6
Evaluation of Bone Mineral Density in Lung Transplant Recipients by Chest Computed Tomography.
Mori R; Handa T; Ohsumi A and 16 more (2023) - Transparency Score: 3/6
Real-World Characteristics of Patients with Severe Asthma prior to Starting Dupilumab: The ProVENT …
Korn S; Schmidt O; Timmermann H and 8 more (2023) - Transparency Score: 3/6
View All Papers from This Journal
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Conflict of Interest Statement J.E.H., T.D.K., M.D., and O.C. have nothing to disclose. K.K. discloses honoraria for lectures from PulmonX. D.-J.S. discloses grants or contracts from PulmonX Corp, PneumRx/BTG/Boston Sc, FreeFlowMedical, Nuvaira, Gala, CSA Medical, and Apreo (all USA), consulting fees from PulmonX Corp, PneumRx/BTG/Boston Sc, Nuvaira, and Apreo (all USA), support for attending meetings and/or travel from PulmonX Corp, PneumRx/BTG/Boston Sc, and Nuvaira (all USA), and receipt of equipment, material, or other services from PulmonX Corp., PneumRx/BTG/Boston Sc, FreeFlowMedical, Nuvaira, PulmAir, GALA, and CSA Medical (all USA)."

Evidence found in paper:

"The authors did not receive any funding or other support for this project."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025